Healthcare >> CEO Interviews >> November 8, 2004
TWST: Would you start us off with a short history of IntegraMed and a Jay Higham joined IntegraMed in October 1994 as Vice President of Marketing and
Development when the company had four locations, $8mm in revenue and a $4mm
operating loss focusing exclusively on providing fertility medical services. Mr.
Higham was the architect of the company's growth and diversification plan that
led the company to over 130 locations, 25% share of the U.S. market for
fertility services as well as the largest U.S. group providing varicose vein
treatment. Mr. Higham became President & COO in July, 2004 and then President &
CEO in January, 2006. In 2008, the company approached $200mm in revenues and
over the last five years the company has achieved over 25% compound annual
growth rate in net income. Four years prior to joining the Company, Mr. Higham
held a variety of executive management positions at various health care service
organizations where he developed and implemented strategies for integrating
physician practices and managed care payers. From 1987 to 1990, Mr. Higham was a
Senior Consultant at Ophnet, Inc., where he focused on practice development,
marketing and sales for high technology specialty physician groups. From 1983 to
1987, Mr. Higham held a variety of executive management positions at Carle
Clinic Association, a 300 physician multi-specialty group practice. Under Mr.
Higham's direction, Carle Clinic expanded its regional presence through
aggressive acquisition and new practice start-ups. Profile
brief overview of what you do?
Mr. Higham: In 2005 IntegraMed will be celebrating its 20th year in
business. For the last